3652 results for «239»

Filter By

3652 results

Left main PCI: predictions of risk and long-term clinical outcome

22 May 2026 – From EuroPCR 2026

This session focuses on risk prediction and long-term outcomes following left main percutaneous coronary intervention (PCI). It covers biomarkers like NT-proBNP, hemodynamic predictors, and the impact of comorbidities such as diabetes and chronic kidney disease on patient prognosis over a ten-year follow-up.

INOCA in patients with coronary artery disease

21 May 2026 – From EuroPCR 2026

This session focuses on ischaemia with non-obstructive coronary arteries (INOCA) in patients with coronary artery disease. It raises awareness of common clinical presentations, emphasizes accurate diagnosis through functional coronary testing, and discusses how tailored treatment strategies can improve patient outcomes in this frequently under-recognized condition.

INOCA in patients with coronary artery disease

Right-sided interventions and impact on the right heart

22 May 2026 – From EuroPCR 2026

This session examines right-sided cardiac interventions and their impact on right heart function. Topics include prognostic implications of right ventricular wall tension, novel metrics for RV-PA coupling, clinical effects of severe tricuspid regurgitation, and strategies for transcatheter pulmonary valve replacement in complex right ventricular outflow tract...

Calcium in the coronary arteries - What could go wrong?

22 May 2026 – From EuroPCR 2026

This session delves into the complexities of treating calcified coronary artery lesions, highlighting strategic selection of PCI approaches, anticipation of potential complications, and agile adaptation of techniques to manage these challenges effectively. Featuring real-world cases from Ireland and the United Kingdom, it provides critical learnings on...

Technical decision-making for CTO PCI strategy

22 May 2026 – From EuroPCR 2026

This session focuses on technical decision-making for chronic total occlusion PCI strategy. It presents diverse approaches to right coronary CTOs, complex management involving double rendezvous techniques, subintimal strategies, and innovative single-injection methods, demonstrating the evolving frontiers in CTO intervention.

Challenges for TAVI in bicuspid

22 May 2026 – From EuroPCR 2026

This session addresses the unique challenges encountered during transcatheter aortic valve implantation (TAVI) in patients with bicuspid aortic valves. It covers procedural nuances for type 0 bicuspid valves, risks associated with anomalous coronary anatomy, and complex anatomical considerations such as large annulus and tortuous aorta, culminating...

Challenging PCI on bifurcation lesions

22 May 2026 – From EuroPCR 2026

Addressing the complexities of PCI in bifurcation lesions, this session highlights novel techniques such as the TAP and modified mini-crush methods, alongside strategies for managing challenging coronary anatomy. Validation of novel approaches like POT-side DCB-POT for left main bifurcations is also featured.

Asymptomatic high-risk patients: can CT coronary angiography improve our practice?

21 May 2026 – From EuroPCR 2026

This session examines the role of cardiac computed tomography (CT) coronary angiography in improving clinical practice for asymptomatic high-risk patients. It discusses detection of vulnerable plaque features, the importance of inflammation and physiology in risk assessment, and explores individualized treatment pathways including PCI, medical therapy, or...

Asymptomatic high-risk patients: can CT coronary angiography improve our practice?

News regarding the SIRONA Randomized Trial

10 Feb 2022

EuroPCR 2024: Primary outcomes from PINNACLE I clinical trial establish safety and effectiveness of Elixir Medical’s Hertz Contact Intravascular Lithotripsy System for calcium fragmentation in moderate to severe calcified coronary artery lesions

16 May 2024

BioCardia reports positive interim results from phase III CardiAMP cell therapy heart failure trial, with compelling data in subgroup with elevated NTproBNP biomarker for heart failure.

04 Mar 2024

TRILUMINATE pivotal: A landmark randomized clinical trial of transcatheter tricuspid valve edge-to-edge repair for tricuspid regurgitation

04 Mar 2023

Jonathan Curio and Alex Sticchi provide their take on this clinical trial which was presented by Paul Sorajja at the American College of Cardiology Scientific Session (ACC.23/WCC).

Alessandro Sticchi

Author

Alessandro Sticchi
Jonathan Curio

Author

Jonathan Curio
Live from ACC.23/WCC: TRILUMINATE pivotal
Didn’t find what you were looking for?